Neurological & Dopaminergic Pathways Some preclinical research has investigated BPC-157's interaction with dopaminergic and serotonergic systems, as well as its potential neuroprotective properties in brain lesion and traumatic injury models
Precursor: A building-block compound the body can use to make glutathione, often discussed when supporting endogenous production
the Companys plans to enter into licensing, partnership, collaboration, manufacturing, or other commercial agreements in connection with its products and delivery platforms
A comparative study of the BPC 157 beneficial effect was done with intraperitoneal application, once daily, intraperitoneally (per kg body weight) 10 g, 10 ng, or 10 pg BPC 157, while standard agents 10 mg atropine, 50 mg ranitidine, and 50 mg omeprazole provide only a weak effect